These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2221963)

  • 1. Slow release carbamazepine in treatment of poorly controlled seizures.
    Ryan SW; Forsythe I; Hartley R; Haworth M; Bowmer CJ
    Arch Dis Child; 1990 Sep; 65(9):930-5. PubMed ID: 2221963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy.
    Arvidsson J; Nilsson HL; Sandstedt P; Steinwall G; Tonnby B; Flesch G
    J Child Neurol; 1995 Mar; 10(2):114-7. PubMed ID: 7782600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine.
    Persson LI; Ben-Menachem E; Bengtsson E; Heinonen E
    Epilepsy Res; 1990 Jul; 6(2):134-40. PubMed ID: 2201541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.
    Eeg-Olofsson O; Nilsson HL; Tonnby B; Arvidsson J; Grahn PA; Gylje H; Larsson C; Norén L
    J Child Neurol; 1990 Apr; 5(2):159-65. PubMed ID: 2111837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
    Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
    Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation.
    Kaski M; Heinonen E; Sivenius J; Tuominen J; Anttila M
    J Ment Defic Res; 1991 Jun; 35 ( Pt 3)():231-9. PubMed ID: 1920391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the range of plasma carbamazepine concentrations in patients with epilepsy.
    Racine-Poon A; Dubois JP
    Stat Med; 1989 Nov; 8(11):1327-37. PubMed ID: 2609045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative open trial of carbamazepine and slow-release carbamazepine in epilepsy in adults].
    Remy C
    Presse Med; 1990 Mar; 19(11):511-3. PubMed ID: 2138749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough seizures with generic carbamazepine: a consequence of poorer bioavailability?
    Hartley R; Aleksandrowicz J; Ng PC; McLain B; Bowmer CJ; Forsythe WI
    Br J Clin Pract; 1990 Jul; 44(7):270-3. PubMed ID: 2206824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation.
    Nag D; Garg RK; Agarwal A
    J Assoc Physicians India; 1998 Feb; 46(2):185-8. PubMed ID: 11273108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state carbamazepine plasma concentration-dose ratios in epileptic patients.
    Sánchez A; Durán JA; Serrano JS
    Clin Pharmacokinet; 1986; 11(5):411-4. PubMed ID: 3780114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady state concentrations and diurnal fluctuations of carbamazepine in patients after different slow release formulations.
    Wolf P; May T; Tiska G; Schreiber G
    Arzneimittelforschung; 1992 Mar; 42(3):284-8. PubMed ID: 1497685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic drug monitoring and the pharmacokinetics of carbamazepine in children with a convulsive syndrome].
    Kholodov LE; Prityko AG; Ivanova ES; Sokolov AV; Tishchenkova IF; Dubrovina LIu; Postnikov SS; Tatarinov PA; Kopanev IuA; Veselov NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(3):35-40. PubMed ID: 7571921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid loading of critically ill patients with carbamazepine suspension.
    Miles MV; Lawless ST; Tennison MB; Zaritsky AL; Greenwood RS
    Pediatrics; 1990 Aug; 86(2):263-6. PubMed ID: 2371100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The optimization of epilepsy therapy with finlepsin].
    Gromov SA; Khorshev SK; Mikhaĭlov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):32-5. PubMed ID: 11026133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to carbamazepine in children with newly diagnosed partial onset epilepsy.
    Holland KD; Glauser TA
    Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.